The Latest Breaking News from Alzheimer Disease

The UK’s drugs regulator – the MHRA – has approved the Alzheimer’s drug donanemab, but it won’t be available on the NHS.

Falling for financial scams may be an early indicator of Alzheimer's among older adults.

Donanemab and another new drug for Alzheimer’s called Lecanemab have been billed as a huge step forward in research

Light pollution is a growing issue. Over the past 25 years, artificial lighting has surged by 49% worldwide. For perspective, the brightness of the night sky has risen by almost 10% per year over the last 12 years. Around 80% of the global population is now affected by light pollution.

Alzheimer's can be passed down from parents to children, but new research reveals whether a particular parent is more likely to be responsible.

Excessive light pollution increases the risk of Alzheimer's in both older and younger adults. For those under 65, nighttime light exposure poses a greater risk of developing Alzheimer's disease compared to many other known factors.

A letter citing 10 studies, published by the American Journal of the Medical Sciences, says picking your nose could increase risk of dementia

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower risk of dementia.

Lecanemab has been deamed too expensive for use on the NHS.